Eating Disorder Clinical Trial
Official title:
Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors
The purpose of this proposed project is to test whether several biological factors (such as elevated brain reward region and attention region response to high-calorie foods, weaker inhibitory region response to high-calorie foods, habitual caloric deprivation, and elevated limbic region responsivity) increase the risk of problematic eating (bingeing and purging) in female adolescents.
Participants will be adolescent girls aged 13-16, some of whom will have parental history of eating pathology. Participants will be recruited from the general population but their age, gender, and the presence of parental lifetime eating pathology will create a high-risk sample. The goals of the proposed project are to (1) conduct a prospective high-risk study to test whether proposed biological risk factors predict the future onset of core ED symptoms (e.g., binge eating, compensatory behaviors); (2) test hypotheses regarding how these biological risk factors and established self-report ED risk factors may work together to predict ED behavior onset; (3) examine if certain biological factors account for the effects of certain established self-reported ED risk factors (e.g., elevated brain response to thin models accounts for the effect of questionnaire-measured thin-ideal internalization). The participants will complete a baseline assessment and then follow-ups assessments over a span of three years. In addition, participants will complete one fMRI scan after the first assessment. During the COVID-19 shelter-at-home order, the investigators will not measure in person only outcomes including fMRI scans, height and weight measurement for BMI calculation nor IAT computer paradigms for all participants that have assessments due during this order. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03317587 -
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
|
N/A | |
Completed |
NCT03197519 -
Evaluation of a Program for Eating Disorders That Combines Cognitive-behavioral Therapy With Online Psychological Treatment
|
N/A | |
Withdrawn |
NCT02978742 -
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder
|
N/A | |
Completed |
NCT03013244 -
Reducing Eating Disorder Risk Factors Among College-Aged Males
|
N/A | |
Completed |
NCT02419326 -
Uniting Couples In the Treatment of Eating Disorders (UNITE)
|
N/A | |
Completed |
NCT00184301 -
A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.
|
N/A | |
Recruiting |
NCT03503981 -
Examining Change Mechanisms in Psychotherapy
|
||
Completed |
NCT03911674 -
Effects of Oral Stimulation in Preterm Infants
|
Phase 3 | |
Completed |
NCT03097874 -
Adaptive Treatment for Adolescent Anorexia Nervosa
|
N/A | |
Recruiting |
NCT03218670 -
Your Health in On Click
|
N/A | |
Completed |
NCT03292146 -
Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
|
Phase 3 | |
Completed |
NCT03502564 -
Integrated Treatment for Co-occurring Eating Disorders and Posttraumatic Stress Disorder
|
N/A | |
Recruiting |
NCT02960152 -
Periodontal Impact of Eating Disorders (the PERIOED Study)
|
N/A | |
Completed |
NCT01985178 -
Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders
|
N/A | |
Terminated |
NCT01183377 -
Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007
|
N/A | |
Completed |
NCT00000448 -
Naltrexone Treatment for Alcoholic Women
|
Phase 4 | |
Completed |
NCT06230107 -
The Effects of Nutritional Intervention in Participants With Eating Disorders.
|
N/A | |
Completed |
NCT03712748 -
Online Imaginal Exposure
|
N/A | |
Completed |
NCT04091477 -
Impact of Neuropsychological Alteration of Patients With Eating Disorders
|
||
Completed |
NCT03317379 -
Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy
|
N/A |